Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Winge

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleusKristian Winge, Kurt Krøyer Nielsen, Hans Stimpel, et al.
Molecular Neurodegeneration|June 9, 2017
Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategiesTomasz Brudek, Kristian Winge, Jonas Folke, et al.
Biomarkers in Medicine|April 10, 2014
The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluidLisette Salvesen, Julia T Tanassi, Sara Bech, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 28, 2020
TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral SclerosisAnne Kallehauge Nielsen, Jonas Folke, Sylwia Owczarek, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|October 31, 2022
Clinical Markers of 6 Pre-dominant Coping Behaviors in Living With Parkinson Disease: A Convergent Mixed Methods StudyTrine Hørmann Thomsen, Lene Bastrup Jørgensen, Troels Wesenberg Kjær, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2018
The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian SyndromesCharlotte Starhof, Anne-Mette Hejl, Niels H H Heegaard, et al.
Neurobiology of Disease|December 3, 2014
Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological studyLisette Salvesen, Birgitte H Ullerup, Fatma B Sunay, et al.
Neuroscience Letters|September 17, 2013
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the diseaseIngemar Björkhem, Anita Lövgren-Sandblom, Valerio Leoni, et al.
Parkinsonism & Related Disorders|January 21, 2024
Identifying the prevalence of Parkinson's disease in Denmark using healthcare registries and self-reported survey dataVicky L Joshi, Knud Juel, Jette Thuesen, et al.
Neurobiology of Disease|July 23, 2017
Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patientsRasmus Rydbirk, Betina Elfving, Mille Dahl Andersen, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleusKristian Winge, Kurt Krøyer Nielsen, Hans Stimpel, et al.
Molecular Neurodegeneration|June 9, 2017
Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategiesTomasz Brudek, Kristian Winge, Jonas Folke, et al.
Biomarkers in Medicine|April 10, 2014
The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluidLisette Salvesen, Julia T Tanassi, Sara Bech, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 28, 2020
TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral SclerosisAnne Kallehauge Nielsen, Jonas Folke, Sylwia Owczarek, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|October 31, 2022
Clinical Markers of 6 Pre-dominant Coping Behaviors in Living With Parkinson Disease: A Convergent Mixed Methods StudyTrine Hørmann Thomsen, Lene Bastrup Jørgensen, Troels Wesenberg Kjær, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2018
The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian SyndromesCharlotte Starhof, Anne-Mette Hejl, Niels H H Heegaard, et al.
Neurobiology of Disease|December 3, 2014
Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological studyLisette Salvesen, Birgitte H Ullerup, Fatma B Sunay, et al.
Neuroscience Letters|September 17, 2013
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the diseaseIngemar Björkhem, Anita Lövgren-Sandblom, Valerio Leoni, et al.
Parkinsonism & Related Disorders|January 21, 2024
Identifying the prevalence of Parkinson's disease in Denmark using healthcare registries and self-reported survey dataVicky L Joshi, Knud Juel, Jette Thuesen, et al.
Neurobiology of Disease|July 23, 2017
Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patientsRasmus Rydbirk, Betina Elfving, Mille Dahl Andersen, et al.
Pageof 5